Loading the company…
Loading the company…
㈜시지바이오
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Gyeonggi, founded in 2006. Industry: Bio & Pharma. Group consolidated revenue for 2025 was ₩244.3bn — this includes subsidiaries and is not the revenue of this entity alone. Workforce data is being verified. It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Patent list being verified. We show the counts together with the list once it is checked.
KIPO KIPRIS · checked 2026-10-15
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 200.9 | 244.3 |
| Cost of sales | 102.1 | 117.2 |
| Gross profit (loss) | 98.8 | 127.1 |
| Selling, general and administrative expenses | 92.3 | 95.4 |
| Operating income (loss) | 6.5 | 31.7 |
| Non-operating income | 5.5 | 2.9 |
| Other gains | 0.4 | 0.2 |
| Finance income | 1.6 | 1.3 |
| Other | 3.4 | 1.4 |
| Non-operating expenses | 8.9 | 10.1 |
| Other losses | 0.2 | 0.0 |
| Finance costs | 4.0 | 4.1 |
| Other | 4.7 | 6.0 |
| Profit (loss) before tax | 3.1 | 24.5 |
| Income tax expense | 0.5 | 0.8 |
Revenue ₩244.3bn, up 21.6% YoY.
Operating margin 13.0% (prior 3.3%).
Net income —.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.
Headlines and links to public articles only · not checked by us (original ↗) · articles are in Korean — English headlines are our translation; where none is shown, “Read in English ›” opens a machine translation · “Broker view” is a forecast, not reported results · checked 2026-11-05